Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Exercise program for women with ovarian cancer before surgery

Official title: The Impact of Prehabilitation Exercise on Frailty and Treatment Outcomes in Ovarian Cancer Patients

Run by Nova Scotia Health Authority · NCT05364879 · Data updated 2026-11-12

This study tests whether a structured exercise program can help women with advanced ovarian cancer get stronger and recover better before their surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment108 (estimated)
SponsorNova Scotia Health Authority
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Halifax, Nova Scotia)
StatusRecruiting
StartedJanuary 3, 2023
Main results expectedAugust 31, 2027
Study endsAugust 31, 2027
Registry record updatedJune 1, 2026
Trial IDNCT05364879 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18 or older with a confirmed diagnosis of stage III or IV ovarian cancer who are scheduled for cytoreductive surgery.

Probably not a fit

Patients who have already undergone surgery or have significant health issues that prevent safe participation in exercise will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on prehabilitation for women diagnosed with stage III or IV ovarian cancer, aiming to improve their physical condition before undergoing cytoreductive surgery. The intervention involves a structured exercise program designed to address frailty, which is common among these patients and can negatively impact surgical outcomes. Participants will engage in in-person and/or virtual exercise sessions, with a minimum of four weeks between enrollment and surgery to allow for adequate preparation. The goal is to enhance recovery and reduce complications associated with surgery.

Why it matters

Potential benefit: If successful, this approach could lead to improved surgical outcomes and recovery for women with ovarian cancer.

How similar studies have gone: While the specific approach of prehabilitation for ovarian cancer is novel, similar interventions in other cancer types have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years or older
* Have a confirmed diagnosis of stage III or IV ovarian cancer
* Scheduled to receive cytoreductive surgery as part of their treatment plan
* Must have a minimum of 4-weeks between the time of study enrollment and scheduled surgery
* Be able to attend in-person and/or virtual exercise sessions
* Be fluent in English
* Have oncologist approval

Exclusion Criteria:

* Have already completed surgery
* Unstable cardiac or respiratory disease, injury or any other co-morbid disease that may make it unsafe for participants to exercise
* Significant cognitive impairment (e.g., do not have the capacity to consent, unable to follow exercise instructions)

Where it's running

  • Nova Scotia Health
    Halifax, Nova Scotia, Canada
    Recruiting

Study contacts

  • Principal investigator: Scott Grandy, PhD — Nova Scotia Health
  • Study coordinator: Scott Grandy, PhD
  • Email: grandy@dal.ca
  • Phone: 902-494-1145

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.